FOLLOW US

Endocrinology Research Updates

For Medical Professionals

Rising use of checkpoint inhibitors for cancer treatment may lead to autoimmune type 1 diabetes as well as thyroid disorders and pituitary issues.
FDA clears diabetes devices that fulfill patient desires for fully automate interoperability between glucose management products to work in real life settings.
Breakthrough in understanding of resistant hypertension points to hormone imbalance as the reason for failure to respond to standard blood pressure treatment.
close X
SHOW MAIN MENU
SHOW SUB MENU